Thalidomide analogs as TNF-alpha modulators
Details for Australian Patent Application No. 2004274474 (hide)
International Classifications
Event Publications
30 March 2006 PCT application entered the National Phase
PCT publication WO2005/028436 Priority application(s): WO2005/028436
24 February 2011 Alteration of Name
The name of the applicant has been altered to The Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services; Brossi, A.; Giordano, T.
10 March 2011 Application Accepted
Published as AU-B-2004274474
7 July 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004274475-Novel adenosine A3 receptor agonists
2004274472-System and method for removing arsenite and arsenate from water
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser